Expertise in
4
conditions

Victoria J. Bray

Campbell Street, 
Liverpool, NSW, AU 
Expertise in
4
conditions
Campbell Street, 
Liverpool, NSW, AU 
OverviewLocationsClinical Research

Overview

Victoria Bray practices in Liverpool, Australia. Ms. Bray is highly rated in 4 conditions, according to our data. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Her clinical research consists of co-authoring 56 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Campbell Street, Liverpool, NSW 2170, Australia
Other Locations
Chris O'Brien Lifehouse, 119-143 Missenden Road, Camperdown, NSW 2050, Australia
Corner Of Goulburn And Elizabeth Streets, Liverpool, NSW 2170, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
Enrollment Status: Completed
Publish Date: July 18, 2025
Intervention Type: Drug
Study Drug: Durvalumab
Study Phase: Phase 3
A Phase 2 Trial of Durvalumab (MEDI4736) and Tremelimumab With Chemotherapy in Metastatic EGFR Mutant Non-squamous Non-small Cell Lung Cancer (NSCLC) Following Progression on EGFR Tyrosine Kinase Inhibitors (TKIs)
A Phase 2 Trial of Durvalumab (MEDI4736) and Tremelimumab With Chemotherapy in Metastatic EGFR Mutant Non-squamous Non-small Cell Lung Cancer (NSCLC) Following Progression on EGFR Tyrosine Kinase Inhibitors (TKIs)
Enrollment Status: Unknown
Publish Date: April 21, 2023
Intervention Type: Drug
Study Drugs: Tremelimumab, Durvalumab
Study Phase: Phase 2
View 1 Less Clinical Trial

56 Total Publications

Documentation of Advance Care Planning in Early Phase Cancer Clinical Trials: An Australian Single-Centre Experience.
Documentation of Advance Care Planning in Early Phase Cancer Clinical Trials: An Australian Single-Centre Experience.
Journal: Cancers
Published: October 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bray's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile